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2. Executive Summary  
 
China pursued an aggressive investment path on biotechnology staring early 1980s. 
Investments in human, financial and technical resources yielded an impressive innovative 
environment that created multiple agricultural, medical and industrial applications. In agriculture 
only a few technologies from the public sector have been approved for commercialization. A smaller 
amount has achieved commercial success. Biosafety procedures were established to ensure the proper 
risk assessment of genetically modified crops and animals as a result from internal regulations as 
well as a result of China signing and ratifying the Cartagena Protocol on Biosafety. China’s biosafety 
system is one of the most advanced in Asia, yet significant regulatory and decision making 
challenges remain to ensure a protective and efficient biosafety system. China rapid progress in 
biotechnology started to decelerate around 2001-2003 and by 2004-2006, its biosafety system was 
enduring criticism from external and some internal sources. In this policy milieu, IDRC provided a 
grant to the Chinese Center for Chinese Agricultural Policy (CCAP) to examine biosafety and 
biotechnology management issues. IDRC in turn requested Dr. Jose Falck Zepeda from IFPRI in 
2009 to conduct an assessment of the CCAP biosafety management project in China. 
Results from the assessment show that the research quality can be considered world class. 
The main focus of the project was to develop conceptual models and to apply state of the art methods 
in field studies as well as to perform regulatory impact assessments. The project’s contribution to the 
field in terms of methodological development, field applications and connecting policy and practice, 
as well as policy outreach are exemplary and receive an excellent mark. The outputs from the 
research have been published in international peer reviewed, national and regional journals, book 
chapters and other types of policy outreach publications. The quality of CCAP publications derived 
from the IDRC project is excellent in technical, and although a literature search does not show many 
citations to the studies covered by the search, the expectations is that this situation will change over 
time based on the history of other CCAP publications on biotechnology and biosafety. 
 
The project has had a significant impact on several stakeholders including the national and 
international scientific community, and policy and decision makers in China. An example of the 
quality and impact of CCAP policy outreach efforts is that China’s government decided to fund a 
major grant through the Chinese Academy of Sciences to fund biosafety and biotechnology 
assessment and management efforts to CCAP. In addition to the publication record, CCAP also 
implemented substantial communication and dissemination strategy including seminars, workshops 
and presentations to decision makers in order to influence public policy as related to biosafety and 
 
 
biotechnology issues. Although CCAP has done an outstanding effort in disseminating its outputs, in 
fact has an exemplary track record in doing this effort, it can benefit from a more slightly more 
structured process for dissemination. The target audiences for the communication and outreach 
outputs were policy and decision makers, the scientific communities, research scientists, biosafety 
regulators and other relevant stakeholders.  
In conclusion, the overall assessment is of an excellent project, outputs and policy outreach 
efforts that has an influence on policy making in China. This constitutes an excellent investment on 
the part of IDRC and certainly has contributed to advancing science in terms of contributions to 
methods and empirical approaches to biotechnology assessment. Furthermore, based on the list of 
pending publications much more publications and impact from the project is expected.  Finally the 
assessment document provides a detailed list of potential research and policy outreach that IDRC 
may pursue in terms of biosafety and biotechnology management in China, sub-regions in Asia and 
at the global level. These recommendations are based on the assessor experience with biotechnology 




3. Evaluation Report  
 
i. Background of the Study 
 
China has made significant investments in human and financial resources focused on 
biotechnology R&D for medical and agricultural applications starting in the early 1980s (Huang 
et al. 2003). Up to 2003, China pursued an aggressive investment policy with the intention of 
positioning itself in a leadership position for biotechnology development (Huang et al. 2001).  
The Chinese government viewed its biotechnology investments as a way to develop tools for 
ensuring food security, raise agricultural productivity, increase farm income foster sustainable 
development and improve its competitive position in international agricultural markets (MOA, 
1990). 
Chinese investment in agricultural biotechnology yielded significant capacity to innovate in 
biotechnology and has created a respectable pipeline for products to be commercialized in the 
near future (Huang et al. 2001; Rodriguez-Cerezo and Stein, 2009).  Indeed China was the first 
country releasing commercially a GM crop and is one of two developing or transition economies 
who have released a public sector GM crop globally. Furthermore, the area planted to insect 
protected (Bt) cotton has increased steadily since its initial deployment (James 2008).  
Up to 2009, however, only Bt cotton has been widely planted commercially of the 48 or more 
events who have received commercialization approval by the relevant regulatory authority, the 
National Biosafety Committee, to 20091
There may be several answers to these questions. Issues such as intellectual property, limited 
capacity or experience with technology transfer, weak institutional frameworks and partnerships, 
and biosafety; may play a role in explaining the limited diffusion of public sector technologies to 
farmers. One additional explanatory factor is that during the period of 2004-2006, the Chinese 
government endured criticisms by non-governmental organizations, pressure groups and other 
.  Around 2004-2006 there seems to be a significant 
pace reduction in terms of investments and movement within the regulatory pipeline, 
commercialization approvals by the NBC and final political approval for commercial release in 
China. If we consider the significant investments in agricultural biotechnology by the public 
sector in China, then relevant questions are Why the holdup? Why more commercial releases by 
the public sector in China have not occurred?  
                                                          
1 China signed the Cartagena Protocol on Biosafety on August 8 2000, ratifying the Protocol on June 8 2005, 
entering into force September 6, 2005. 
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stakeholders in the international policy arena over its biosafety and biotechnology policies and 
its ability for implementation, as well as, questions about the potential impact of GM technology 
adoption on Chinese exports and trade. 
Nevertheless, a small but significant component of China’s investment portfolio in 
biotechnology included ensuring compliance with its own biosafety regulations and the 
Cartagena Protocol on Biosafety (See Box 1). China’s biosafety regulatory development efforts 
ensured that Chinese biosafety laws and regulations cover most of the issues covered by other 
countries with advanced regulatory experience. To date China has accumulated knowledge and 
experience with risk assessments for experimentation, confined field trials and 
commercialization approvals to the point that its biosafety legislation has been modified over the 
last decade to improve efficiency and reduce implementation costs.  
The later assessment does not mean that the biosafety management in China cannot be improved. 
By definition, biosafety regulatory systems learn and adapt over time when addressing 
increasingly more complex technologies and/or while the scope of decision making systems 
expand to include broader considerations beyond strict biosafety issues.  In this policy milieu the 
need arose for an evaluation and examination of China’s biosafety system procedures to improve 
its efficacy, efficiency, and transparency that would build a protective and enabling system (Jaffe 
2006). At this juncture of China’s biosafety regulatory system, The Center for Chinese 
Agricultural Policy (CCAP)2
Major activities developed during the implementation of the IDRC project included policy, laws 
and regulations reviews, workshops,  stakeholder interviews, development Bt cotton production 
practices database, analysis on the potential economic impacts of the Biosafety Protocol on trade, 
implementation Bt cotton production and seed market surveys. In addition the project collected 
cotton seeds and leaves for Bt gene expression tests, data cleaning and compilation, analysis and 
publication preparations. Important to note that the objectives and activities included in CCAP’s 
Final Technical Report submitted to IDRC (See Box 2) are slightly different than in the original 
proposal submitted to IDRC. All adjustments and changes were approved by IDRC after annual 
or periodical reports during the course of implementing the project.  
 a premier research organization in China (See Box 2) obtained a 
grant from IDRC to examine a portfolio of biosafety regulatory implementation and management 
questions in China. 
                                                          






Description of the methodology employed 
I performed the assessment of the CCAP project funded by IDRC, through the examination of 
CCAPs Final Technical Report, CCAP Project Brief, and list of outputs (see Annex 1) submitted 
to me in the course of the evaluation. In addition I performed a literature search using the 
program “Publish or Perish” to examine biotechnology and biosafety publications cited in 
Google Scholar by team members participating in the project. Furthermore, I conducted several 
interviews with the project leader, Dr. Jikun Huang, team members and collaborators and 
potential beneficiaries of the project, as well as external experts familiar with the project and 
CCAP and its accomplishments. Annex 2 contains a full list of persons interviewed, consulted or 
with I discussed the CCAP project and biosafety and biotechnology issues in China.  Parts of the 
draft report and potential future activities in China was discussed with a small group of experts 
and project personnel convened by the assessor during a visit by the assessor to China for the 
meeting of the International Agricultural Economics Association in Beijing, August 16 - 22, 
2009. 
Box 1. China Policy on Biosafety 
According to the National Biosafety Framework of China, the policy for biosafety of China contains the following elements: 
(1)  The overall objective for national biosafety management is to ensure that the risks likely to be caused by modern biotechnology and its 
products will be minimized and biodiversity, human health and environment will be protected in a maximum way, while promoting research, 
development and commercialization of modern biotechnology through formulation of policies, regulations and relevant technical guidelines. 
(2)  The overall principles for national biosafety management consist of the principle of encouraging the research and development of 
biotechnology, combined with the precautionary approach, prevention as priority, coordination and cooperation between government departments, 
science-based management, public participation and strengthening the international cooperation on biosafety affairs. 
(3)  According to different risk levels, different measures such as encouraging, limiting and forbidding the commercialization, sales and use of 
different types of LMOs and their products, are adopted. The production, sales and consumption of LMOs and their products with low risks are 
encouraged, while the production of LMOs and their products with high risks are prohibited, to minimize the adverse impacts to biodiversity, 
human health and environment which likely caused in the process of production, transportation, sales and utilization of LMOs. 






Project methods strengths and weaknesses 
Undertaking an evaluation of policy, decision making and stakeholder impacts from a research 
project has many limitations including impact attribution, tracing and determination of indirect 
impact, identification of the impact pathway. The best practice approach is to use several 
methodological approaches as is done in this evaluation. Interviews with experts, literature 
review, examination of research outputs, tracing of impacts and the familiarity of the assessor 
with the research program, are a major strength of the current assessment.  
Due to time and resources limitations, I only managed to interview a relatively small number of 
stakeholders and/or persons familiar with the IDRC project. The window of opportunity for 
contacting relevant persons was too small as many of the policy makers were also involved in the 
International Agricultural Economics Conference in Beijing, as the Ministry of Agriculture and 
other relevant Ministries co-sponsored the event. Time and resource limitations were not the only 
two issues limiting access to personal interviews. As biosafety and biotechnology remain a 
sensitive topic in China, attempts made to contact independently other policy and decision 
makers involved with the biosafety review process and GM crop approval process were not 
successful. Several attempts were made independently to contact relevant persons familiar with 
CCAP and the IDRC project, which were not successful or were re-directed to public relations or 
information officers who provided standard information material or politely refused to respond 
questions about biosafety and biotechnology policy beyond what was contained in the 
information provided. The information collected was therefore heavily supplemented with the 
submitted outputs, literature reviews, literature searches and examination of other materials 
relevant to the assessment. Certainly literature searches and reviews have limitations and 
Box 2 IDRC Project Biosafety Management of Genetically Modified Crops after Their Commercialization 
Overall Goal  
The overall goal of the project is to improve farmers’ income, food security, and the health of rural people through the development of a biosafety 
regulatory system, a healthy input market and an efficient public service sector that will ensure farmers better access to new technology, knowledge 
and information. 
Major Objectives: 
1) To have a better understanding of the policy making process and the institutions and biosafety regulations governing GM technology 
2) To have a better understanding of long-run benefits of GM technology (Bt cotton) to small farmers in rural China 
3) To have better understanding of the performance of seed market, farmers’ practical choices of seeds available in the market, including approved 
or unapproved Bt cotton seed by biosafety committee, and their impacts on the productivity of Bt cotton technology 
4) To have a better understanding of the performance of insecticide market and pest-control behaviors of farmers in Bt cotton production 
5) To evaluate the effectiveness of recent policies on seed subsidies, IPR enforcement and other regulations on the productivity of Bt cotton at farm 
level; and  
6) To generate policy implications for future GM technology development that will contribute China’s food and nutritional security and lend 
valuable lessons to other developing countries in Asia and beyond. 
 
Cooperating units: Stanford University; Rutgers University; Chinese Academy of Agricultural Sciences 
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weaknesses of their own as they are an excellent indication of contributions to the field and 
methods, but may not be a good indicator of policy and decision making intake and use of 
project results, thus the need for consultations with experts and persons familiar with the project.  
 
ii. Activities and Achievements 
 
Evaluation Findings 
Outputs submitted by IDRC and by Dr. Jikun Huang (Project Leader) include the final IDRC 
technical report, one M. Sc. thesis, three Ph.D. dissertation, six journal articles, one book 
chapter, one policy brief and several presentations in addition to a list of expected outputs to be 
delivered shortly after the formal end of the project. The later include one book, and additional 
journal articles.   
The outputs produced during the project are numerous and of an excellent quality.  The assessor 
does not have any doubt that the outputs produced by the project which have not been published 
yet in reputable peer reviewed journals, will be published, given sufficient time. Although the 
citation statistics do not show that the biosafety articles have been cited much in the literature in 
Google Scholar yet (See Annex 6 Table A.6.1) this fact is not surprising there has been a very 
limited time lag between publication and the literature search performed by the assessor. Based 
on the track record, including publication history and professional relevance shown by the 
members of the CCAP team members for biotechnology economic assessments, the assessor 
expects that citations will indeed pick up.   
Table A.6.1 in Annex 6 also shows the quality of outputs produced by CCAP in the 
biotechnology and biosafety arena. More than 63 publications have been published in peer 
reviewed publications as documented by the software “Publish or Perish.”3
Research quality  
 As seen in Table 
A.6.2 the impact of such publications, as measure by citations, is excellent. Some of the 
publications presented here have one of the highest citation scores I have seen for the agricultural 
economics literature, especially for developing and transition economies literature. 
 
                                                          
3 This software searches in Google Scholar and therefore will yield a different count than the social index 
aggregators. The advantage of using this software is that it is easy to use allowing calculating impact 
coefficients in a rapid manner. 
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The quality of the research outputs produced by CCAP in the IDRC project is simply 
outstanding. The focus of the research was not the development of theory or conceptual models, 
rather the innovative application of methods for field work in areas not addressed by researchers 
in the past. Certainly the CCAP project provided ample applications for policy research analysis 
and practice which I can assess as being world class in quality.  
The practical applications in the CCAP project addressing refuge management, insect damage 
and control, secondary pest damage, pesticide use and economic performance are excellent, and 
are state of the art in terms of methodology applications. The work on consumer issues is quite 
advanced in terms of methods and is one of the first studies done for China and Asia4
Biosafety regulations 
. The 
specific biosafety applications to IPR and biosafety regulatory design and decision making still 
need some development. However, this is a reflection of the existing narrow foundation in terms 
of theory and conceptual models in the literature. Several issues remain to be examined in order 
to address the multiple questions regarding biosafety and those that may be limiting the transfer 
of GM biotechnologies to farmers in China. Reviewing specific results from the CCAP study 
illustrates the quality of its research.    
Strict application of biosafety regulations raises productivity slightly but induces a delay in the 
release of a technology to farmers. Implementation of the basic mandates of the Cartagena 
Protocol induces moderate impacts for China agriculture, simply because the country already has 
a functional biosafety system. The system indeed needs support in terms of redesign and 
improvements in efficiency and efficacy, but these are minor compared to the needs of other 
countries in Southeast Asia. In fact, one of the potential recommendations that will arise from 
this study evaluation is that future investments by IDRC may consider projects that use China’s 
experience in supporting capacity building and strengthening efforts for selected countries in the 
continent and elsewhere.  
Cotton productivity and insect damage abatement/control 
Results from this study show that the impact of Bt cotton on secondary pest’s damage is small. 
This is reflected in the lack of insecticide use increase for controlling secondary pests. Results 
show a robust decline in pest applications over time. However, farmers’ pesticide applications 
                                                          
4 In the consumer assessments, there needs to be much more developments in terms of methods and approaches 
(Smale et al. 2008). 
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are influenced by information and knowledge about the technology and risk preferences. Two 
thirds of the variation in the expression of the Bt protein in the field can be explained by farm 
practices, although there are large variations spatially. 
Consumer and Other Institutional Issues 
Improvements in the IPR environment in China and in the seed sector can increase the level of 
benefits from cotton technologies. In average, seed subsidies are ineffective in raising 
productivity, although this varies spatially. Seed markets in China are quite complex, so much 
that farmers have a difficult time distinguishing superior varieties. As a consequence farmers in 
some instances prefer to save seed which they can expect have a good performance.  
iii. Result: Impact(s) on decision-makers, public or private sector, or in related activities 
 
My assessment of the outstanding quality of CCAP outputs is robust. Where the IDRC project 
really shines, however, is in the built relationship between research, and the policy and decision 
making processes, achieved by CCAP during the IDRC project and beyond. As described 
previously the CCAP project has examined quite comprehensively important cotton productivity 
issues and biosafety regulatory issues and questions. Due to the complex nature of the biosafety 
process, especially as it relates to stakeholder interests and questions, more remains to be done.  
 
Impacts on decision makers 
Based on conversations with Dr. Dafang Huang (Senior Scientist, Former Director 
Biotechnology Research Institute, Beijing) the outputs produced by CCAP and with the CCAP 
team during the lifetime of the IDRC project, were instrumental in the decision by the Chinese 
government to continue supporting biotechnology and biosafety in China. Outputs from the 
IDRC funded project produced by CCAP were also instrumental in the decision by the Chinese 
Government in investing in biosafety and biotechnology innovation and deployment efforts to 
farmers. In fact, the Chinese government provided a grant of approximately US$ 13 million to 
CCAP within the Chinese Academy of Sciences to fund biosafety research and other regulatory 
issues. Furthermore, the project contributed to improving China’s cotton subsidy program by 
proposing and government adopting, more transparent government seed procurement processes 
and bidding mechanisms.  




My analysis of CCAP’s impact on farmers and other stakeholders show that the project has had 
significant impact in China by providing knowledge and information to relevant stakeholders 
especially decision and policy makers. The case where IDRC provided evidence for reforming 
the seed sector and the agricultural extension system made a robust case for further discussion in 
the policy making circles. As China needs to meet its obligations under the CPB, CCAPs work in 
biosafety and its likely impact makes the case for biosafety support in China, mainly to refine 
and improve its existing systems in order to improve efficiency and efficacy, but also to lay the 
groundwork for second and third generation GM crops which will bring more and more 
sophisticated regulatory issues and problems for their risk assessment.  
 
iv. Dissemination 
The original project proposal contemplated a distinct policy outreach strategy for the project. The 
policy outreach strategy followed the track used by CCAP over the last decade that has proven to 
be quite successful with decision makers in China, although there are opportunities for 
improvement, especially once research projects are directed towards ensuring impact on the main 
target groups including producers, consumers and other relevant stakeholders.  
The main targets of the communication and dissemination strategy in the CCAP/IDRC project 
were policy makers and the scientific community in China and abroad. The primary purpose was 
to identify and analyze ongoing biosafety regulatory issues that may be slowing biotechnology 
product deployment in China. In order to be effective, CCAP identified the need to publish in 
international high quality peer reviewed journals that brings credibility to its work, which in turn 
supports dissemination of its research findings to appropriate decision makers. Research outputs 
were presented to decision makers through well thought seminars and other events, as well as 
targeted publications including policy briefs. CCAP are regularly consulted by high-level policy 
makers in China. Therefore, CCAP research conducted during the IDRC project also had the 
objective of influencing policy.  
Project output dissemination, in my opinion, has been to date excellent and indeed has reached 
their intended targets. CCAP has planned additional outputs to be completed after the project 
concluded; these have been trickling over time. Of especial merit, has the emphasis that CCAP 
has put on developing human resources for regulatory impact assessment and other areas of 
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biotechnology evaluation. This will prove to yield long-run impact for policy development and 
implementation in China. 
In the future dissemination and communication can be improved by increasing the sophistication 
of the policy outreach approach within CCAP projects and within other IDRC research 
programs. Here, I define policy outreach as the deliberate communication of sound and solid 
research results to policy makers in order to offer them policy instruments and policy analysis 
alternatives for their consideration and potential use. In fact, I propose including an explicit 
communication and policy outreach component that drives output dissemination via appropriate 
media.  
Any policy outreach strategy, however, has to address critical needs for research results to enter 
the policy domain. To resolve this need and for policy outreach to be successful, any research 
project needs to identify the appropriate decision makers and the most opportune time to 
approach them. Timing and appropriateness of the information conveyed thus become critical to 
maximize research project effectiveness in the field. Furthermore, communication of policy 
messages needs to be targeted carefully to the different and relevant stakeholders and needs to be 
a long-run process that should continue beyond the lifetime of a research project, so that its 
research findings become incorporated into the decision making process as much as possible. 
The implication of this is of course that implementing organizations and ideally the donor, must 
be prepared to fund the suggested policy outreach activities, beyond the life of the project using 
own funds or through additional grants to fund such activities. 
 
v. Audiences 
 In this specific project, the main beneficiaries of the project’s research results where the target 
groups within the decision making community including the Ministry of Agriculture, Ministry of 
Science and Technology, the National Biosafety Committee, and those agencies that set plans 
and budgets within China.  
In the long run, IDRC’s main concern is supporting projects with a positive impact on poverty 
and livelihoods. Implication from the donor’s mission is that policy changes directly impacted by 
a project implemented by CCAP - or other policy groups- need to induce changes that will 
benefit farmers. Demonstrating impact from policy interventions is an important issue for most 
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research policy organizations in agriculture. Research policy organizations therefore need to 
develop roadmaps or pathways for policy impact that document positive impacts on farmers.  
A potential pathway for impact is that if the work done by CCAP does indeed improve the 
effectiveness and efficiency of biosafety systems in China, the improved system ensures the 
proper risk assessment and management of potential technologies. An improved system leads to 
an eventual release of safe and appropriate technologies that have the potential to benefit 
resource poor farmers. We can show that the policy research has indeed yielded impact on its 
ultimate users. The impact pathway then is indirect and predicated on the changes that policy 
options induce in the decision making arena.  
 
vi. Conclusions and recommendations: 
Overall project assessment 
My overall assessment of CCAP project funded by IDRC is that this was an excellent investment 
on the part of IDRC. Outputs quality complies with the highest international standard. The 
CCAP project managed to produce not only outputs of the highest quality but also manage to 
disseminate its products amongst relevant policy and decision making clients. One of the 
consequences of this effective intervention was that the government of China invested significant 
resources funding biosafety management efforts. 
The IDRC project achievements are multiple and of high impact. However, the project can be 
highly commended for managing to influence policy and decision making in China, but also in 
accomplishing its objective of building internal capacity by investing in human resources for 
biosafety regulatory impact assessment.  
Potential research and policy outreach avenues  
 
Based on my interactions with the CCAP team, consulted officials and experts, literature review 
and my own experience with biotechnology, biosafety, technology decision making processes, it 
is my opinion that there are several areas that may be worthwhile pursuing for future funding, 
not only in China and Southeast Asia, but in other parts of the world.  
Potential avenues for research and policy outreach take advantage of countries with advanced 
technical skills in biosafety and biotechnology for building capacity in other countries. 
Furthermore, the proposed avenues respond to the need for increased sophistication of regulatory 
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systems, as they become exposed to a more diversified portfolio of technologies. Certainly, there 
is an opportunity to improve the efficiency and efficacy of China’s biosafety system, which is 
common to other countries with advanced regulatory systems.  
Proposed avenues require exploiting comparative advantage in the region in order to develop or 
augment capacity to address policy issues relevant to national, regional and international 
biosafety systems and countries stemming from excellence-driven research and analysis using 
advanced research methodologies and skills. Policy research can help advance knowledge and 
contribute to sound policy making by augmenting the scope of short term technical regulatory 
assistance by elevating the level of analysis to a systematic, comprehensive and long run view. 
The proposed policy research needs to incorporate the mandate of delivering international public 
goods, as these outputs can benefit not only lead countries but other countries developing or 
implementing biosafety systems, therefore multiplying the possible impacts both across countries 
and overtime. Potential avenues for research and policy outreach projects include:  
Using China’s existing biosafety system to build capacity in the region 
a) Strategically use China’s accumulated expertise with biosafety assessments and decision 
making. Draw experience and that of other countries in Asia (Philippines, Japan, and 
Thailand) to transfer regulatory capacity to lower income countries such as Myanmar, Laos, 
and Vietnam. Even in the case where a country declares itself “GM-free” it still needs some 
regulatory capacity to deal with imports.   
b) Note that it is not necessary to develop huge capacity that will go unused, implies rather 
building capacity as needed. This is especially important as donors need to avoid the 
temptation of building up complex capacity to regulate biosafety issues when it is not needed 
or where a simpler system may suffice. 
Improving China’s biosafety system 
a) China needs to improve transparency and knowledge flows on decisions. Increase 
participation in biosafety decision making by other than biotechnology scientists 
b) Financing biosafety assessments – Identify who should pay for biosafety assessments. This 
area o research needs to define the political economics and power relations that may affect or 
be affected by regulations. 
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c) Develop capacity at the provincial /local level for facilitating compliance to biosafety 
regulations by research institutions but also for monitoring and enforcement purposes. 
d) Implementation regulations in countries with a federal type system. Needs arises for 
addressing the dichotomy between the center and state/provincial/local laws and regulations 
which may enter into a conflict. This includes compliance with biosafety regulations and 
decisions made at the Center with enforcement at the local level 
Biosafety supporting biotechnology decision making 
a) Understanding institutional and legal issues that shape biosafety implementation and 
biotechnology deployment including political economies of biosafety decision making, 
power relationships and regulatory outcomes. Issues such as biotechnology deployment, 
impacts and outcomes, and gender, health and overall poverty alleviation efforts are a must. 
b) Understanding the pillars of biosafety functional capacity and biotechnology decision making 
is a must for designing capacity building and strengthening efforts that will empower 
countries with lesser capacity to build their own functional and enabling systems   
Global policy studies on biosafety issues 
a) Conduct a comprehensive analysis of gene escape events (e.g., illegal or unwanted 
introduction of GM crops) and identify policy options for developing countries focusing on 
the economic considerations of liability and redress, risk evaluation and policy instruments to 
manage such issues.  
b) Reconnect biosafety with the broader context of technology, agriculture and economic 
development. The purpose is to robustly situate biosafety regulatory processes within a 
balanced, well thought and rational decision making processes.  
c) Cross comparative studies on specific biosafety regulatory decision making issues including 
determining the need of insect resistant management strategies, defining appropriate 
environmental impact or risk assessment methodologies, incorporation and timing of socio-
economic considerations and impact assessment procedures, and support in estimating the 






4. Annexes  
 
Annex 1. List of Acronyms  
 
CCAP……….The Center for Chinese Agricultural Policy 
IFPRI………..International Food Policy Research Institute 
MOA……….Ministry of Agriculture 
CBD…………Convention on Biological Diversity 





Annex 2. List of people 
 
The following is a list of people interviewed, contacted, or with whom I discussed (formally or 
informally) IDRC project, CCAP activities, or potential work in biosafety and biotechnology 
policy in China. 
 
Jikun Huang, Director and Project Leader, The Center for Chinese Agricultural Policy 
 
Dafang Huang Senior Scientist, Former Director Biotechnology Research Institute, Beijing, 
China 
 
Ruifa Hu, Senior Scientist, The Center for Chinese Agricultural Policy 
 
Melinda Smale, Senior Scientist, OXFAM America. 
 
Guillaume Gruere, Research Fellow, International Food Policy Research Institute 
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Annex 4. TORs for the evaluation and/or evaluator 
 
TERMS OF REFERENCE (ToR) FOR THE EVALUATION OF THE PROJECT 
BIOSAFETY MANAGEMENT OF GENETICALLY MODIFIED CROPS –CHINA 
(IDRC GRANT NUMBER: 103783-001) 
______________________________________________________________________________ 
 
1. Project Title:  
 





Professor Jikun Huang, Director, Center for Chinese Agricultural Policy, Chinese Academy of 
Sciences (CCAP), Institute of Geographical Sciences and Natural Resources Research, Jia 11, 
Datun Road, Anwai, Beijing 100101, PRC. 
Email: jkhuang.ccap@igsnrr.ac.cn 
 
3. Person responsible for Evaluation: 
 
Dr. Jose Falck-Zepeda, 
Research Fellow / Leader Policy Team Program for Biosafety Systems (PBS) 
Environment and Production Technology Division 
International Food Policy Research Institute (IFPRI) 
2033 K Street NW 







4. Background and Purpose of the Evaluation: 
 
 
5. Period of Evaluation: 
 




The assessment will be largely done through the examination of final technical report, project 
briefs, list of outputs, and examination of final outputs available. Furthermore, the assessor will 
sustain several interviews with the project leader, Dr. Jikun Huang, collaborators and potential 
beneficiaries of the project, as well as external experts familiar with the project and its 
accomplishments.  The evaluator will further discuss evaluation issues and potential avenues for 
research with a small panel of experts convened by the assessor during a visit by the assessor to 
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China for the meeting of the International Agricultural Economics Association in Beijing, 
August 16 - 22, 2009.  
 
7. End of Project Evaluation Structure:   
 
i. Activities and Achievements: 
 
Research Quality:  Examine and comment upon the quality of analysis of the research 
undertaken.   
 
In terms of contributions to the field, how has this project contributed to (a) theory (b) 








• Was a communications/dissemination strategy developed for the project?  
• Who were the main target audience or user of the research? What plans did the 
researchers make to disseminate research findings?  For what primary purpose? (e.g. 
to influence public policy? Contribution to emerging literature? etc.) 
• Has dissemination been to date satisfactory and have the researchers made adequate 
plans for dissemination further results of the research? 
• How might dissemination and communication be improved in the future? 
 
iv. Audiences: 
• Specific audiences who have benefited or may benefit from dissemination of this research. 
 
v. Conclusions and recommendations: 
What is the overall assessment of the achievements of this project? 
 
What are the potential research avenues that may benefit from additional efforts for funding in 
the future in China and other countries in the region? 
 
7. Deliverables and Due Dates: 
 
Deliverable Due Date 
5-7 page draft report answering items ii to iv 
under “End of Project Structure Assessment”  
August 1, 2009 
10 page final report with the inclusion of item 
v “End of Project Structure Assessment” 
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Name:  Jose Benjamin Falck Zepeda   
Organizational affiliation:  Research Fellow, EPTD, International Food Policy Research Institute 
(IFPRI) 
Contact information: IFPRI 
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implications 
2004 Journal of Development … 
48 J Huang, R Hu, Q Wang, J Keeley, JF … Agricultural biotechnology development, policy and impact in China 2002 Economic and Political … 
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Table A.6.2 Citation Analysis using “Publish or Perish” 
Papers 63  h-index: 18 
Cites/paper: 29.67  g-index: 43 
Cites/author: 499.73  hc-index: 14 
Papers/author: 18.52  hI-index:  
Authors/paper: 3.97  hI,norm: 10 
Citations 1,869  AWCR: 222.9 
Hirsch  a=5.77 m=1.13  AW-index: 14.9 
Contemporary  ac=4.55  AWCRpA: 57.8 
Cites/paper  29.67/4.0/0 
(mean/median/mode) 
 e-index: 37.3 
Authors/paper  3.97/4.0/4 
(mean/median/mode) 
 hm-index: 7 
     
2 paper(s) with 1 author(s)     
8 paper(s) with 2 author(s)     
6 paper(s) with 3 author(s)     
25 paper(s) with 4 
author(s) 
    
18 paper(s) with 5 
author(s) 
    
4 paper(s) with 6 author(s)     
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Annex 7. Relevant Biosafety Regulations in the P.R. China 
Safety Administration Implementation Regulation on Agricultural Biological Genetic Engineering (1996) 
The regulation is aimed at promoting research and development in the area of agricultural genetic 
engineering in China, strengthening safety administration, preventing possible hazards caused by GMOs 
and their products to human health and environment on which human beings rely for existence and 
agricultural ecological equilibrium. 
The genetic engineering items covered in the Implementation Regulation include rDNA technology using 
vector systems, and introduction of rDNA into an organism by using physical, chemical and biological 
means. The “Implementation Regulation” is applicable to agricultural organisms whose genome 
constitution has been changed by using genetic engineering technologies. The agricultural organism 
includes plants and animals related to agricultural production, plant-related microorganisms, veterinary 
microorganisms, aquatic animals and plants. 
The organisms that are not included are: 
(a) Plants obtained by spontaneous generation, and by using artificial selection and hybridization 
technologies; from mutagenesis via chemical or physical means; and by using organ culture, tissue culture 
and cell culture as well as protoplast fusion technology and chromosome ploidy manipulation; 
(b) Animals obtained via spontaneous generation and by using artificial selection, artificial insemination 
(excluding rDNA), superovulation, embryo chimera, embryo partition, and nucleus transfer or ploidy 
manipulation technology; 
(c) GM microorganisms (excluding virus and subvirus) obtained by using chemical and physical 
mutagenesis; transfer of non-recombinant DNA via transduction, transformation or conjugation processes. 
Regulation on the Administration of Agricultural Transgenic Biosafety (2001) 
The regulation covers the activities of research, testing, production, processing, marketing, import or 
export of agricultural GMOs within the territories of the People’s Republic of China. These have been 
formulated for the purpose of strengthening safety administration of GMOs, safeguarding human health 
and safety of animals, plants and microorganisms, protecting the environment, and promoting research on 
agricultural GMOs. 
Procedure for the Administration of Assessing Agricultural Transgenic Biosafety (2002) 
Procedure for the Administration of the Safe Import of Agricultural Genetically Modified Organisms 
(2002) 
Procedure for the Examination and Certification of the Labels of Genetically Modified Organisms (2002) 
The procedures focus on the report management and approval, the administration procedures applied to 
the GMOs imported for different purposes and on application, reviewing, cancellation and other 
procedures of agricultural GMOs labeling. 




The Implementation Regulations cover the activities of research, testing, production, processing, 
marketing, import or export with respect to agricultural GMOs within the territories of the People’s 
Republic of China that are required for safety evaluation. These Implementation Regulations are 
formulated in accordance with the “Safety Administration Implementation Regulation on Agricultural 
Biological Genetic Engineering” for the purposes of strengthening the safety assessment administration of 
agricultural GMOs, safeguarding human health and safety of animals, plants and microorganisms, and 
protecting the environment. 
Implementation Regulations on Labeling of Agricultural Genetically Modified Organisms (2004) 
The Implementation Regulations are formulated in accordance with the “Safety Administration 
Implementation Regulation on Agricultural Biological Genetic Engineering” for the purpose of 
strengthening the labeling administration of agricultural GMOs, standardizing the marketing activities of 
agricultural GMOs, guiding the production and consumption of agricultural GMOs, and protecting 
consumers’ right of full access to the information about the products. 
The marketing of any agricultural GMOs listed in the labeling catalogue needs to comply with these 
implementation regulations. All agricultural GMOs listed in this catalogue and intended for marketing 
need to be labeled. As per the regulation, any agricultural GMO without a label or whose label is not in 
conformity with the requirements of these implementation regulations would be banned for import or 
marketing. 
Implementation Regulations on Safety of Import of Agricultural Genetically Modified Organisms (2004) 
The Implementation Regulations are formulated in accordance with “Safety Administration 
Implementation Regulation on Agricultural Biological Genetic Engineering” for the purposes of 
strengthening the safety administration on imported agricultural GMOs, and applies to the safety 
administration of any activity of importing agricultural GMOs and their products into the territories of the 
People’s Republic of China. It covers the import of the agricultural GMOs for research and testing; 
commercial production and as raw material for processing. 
Regulation on Inspection and Quarantine of Import and Export of Genetically Modified Commodities 
(2004) 
This Regulation is applicable for the inspection and quarantine of GM commodities imported and 
exported in all ways including, but not limited to, trading, raw material processing, mail, carrying, 
production, entrusted reproduction, research, exchange, exhibition, aid and grant. It has been formulated 
to strengthen the inspection and quarantine of import and export of GM commodities, safeguarding the 
human health, ensuring the safety of animals, plants and microorganism and protecting the ecological 
environment, based on the Law of The People’s Republic of China on Import and Export Commodity 
Inspection, the Law of The People’s Republic of China on Food Hygiene, the Law of The People’s 
Republic of China on Quarantine of Import and Export Animal and Plants and respective administrative 
rules as well as the Regulation on the Safety Management of Agricultural GMOs. 
Measures on Approval of Agricultural Genetically Modified Organisms Processing (2006) 
The Measures have been formulated in accordance with “Safety Administration Implementation 
Regulation on Agricultural Biological Genetic Engineering” for the purpose of strengthening the safety 
administration on approval of agricultural GMOs processing. It stipulates the qualifications of those who 
26 
 
process agricultural GMOs, the procedures of applying the processing permit, the permit administration, 
etc. 
Decree 10 (CH7053) Labeling Regulation (2007) 
Decree 10 states that the reason for the regulation is “to strengthen the administration of GMO labeling, 
standardize the selling activities of agricultural GMOs, guide the production and consumption of GMOs 
and protect consumers’ right to be informed.” The regulation spells out the type of labeling required as 
well as the specific language that is required on the individual labels. 
Source 
Gupta, Karihaloo, and Khetarpal (2008) based on information by Yu Wenxuan, China University of 
Political Science and Law, China, email: wenxuan_yu@sohu.com, ywenxuan@clapv.org (Personal 
communication) and USDA Foreign Agricultural Service, GAIN Report CH7055: China, Peoples 
Republic of BiotechnologyAnnual 2007. (available at: 
http://www.fas.usda.gov/gainfiles/200707/146291718.doc; accessed on 16 October 2007). 
 
